Carrie L. Bourdow
-
Chesterbrook-Based Trevena’s Stock Surges After FDA Approves New Pain Med
Chesterbrook-based Trevena saw its stock surge by 50 percent after the FDA approved its new pain medicine on Monday, writes John George for the Philadelphia…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
